Methods of screening for TRPM4b modulators
AssigneeThe Queen's Medical Center
InventorsReinhold Penner, Andrea Fleig
Life of this patent
Estimating the term…
Abstract
The invention relates, in part, to methods useful in identifying molecules, that bind TRPM4b, which modulate TRPM4b ion channel activity, and/or which alter expression of TRPM4b within cells. The TRPM4b channels as described herein contain TRPM4b polypeptides, which are in turn encoded by TRPM4b nucleic acids. The ion channels described herein are preferably formed in HEK-293 cells from one or more novel TRPM4b polypeptides, which exhibit one or more of the unique TRPM4b properties described herein.
Claims5
A method for screening for a candidate bioactive agent capable of modulating the monovalent cationic permeability of a recombinant TRPM4b channel, wherein said TRPM4b channel is capable of being activated with calcium in the nanomolar range and wherein said TRPM4b channel is permeable to monovalent cations selected from the group consisting of Na+,K+ and Cs+ without significant calcium permeation, said method comprising the steps of:
- a) activating a recombinant TRPM4b channel;
- b) contacting said recombinant TRPM4b channel with a candidate bioactive agents,
- c) measuring the monovalent cationic permeability of said recombinant TRPM4b channel after said contacting with said candidate bioactive agent;
- d) comparing said monovalent cationic permeability of said recombinant TRPM4b channel after said contacting with said candidate bioactive agent with the cationic permeability of said recombinant TRPM4b channel in the absence of said candidate bioactive agent to determine whether said bioactive candidate agent modulates the monovalent cationic permeability of said recombinant TRPM4b channel.
Dependencies are inferred from the claim text.